Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001104659-23-063261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-18 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $44.35 | -10.5K | 105.1K | -9% | -$465.7K |
| D | 2023-05-22 | 2023-05-19 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | F - Tax | $44.16 | -378 | 104.8K | -0.4% | -$16.7K |
| D | 2023-05-22 | 2023-05-18 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $13.35 | +10.5K | 115.6K | +10% | +$140.2K |
| D | 2023-05-22 | 2023-05-18 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -10.5K | 18.5K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | S | D | 10,500 | $44.35 | 105,148 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-19 | F | D | 378 | $44.16 | 104,770 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-18 | M | A | 10,500 | $13.35 | 115,648 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-05-18 | M | D | 10,500 | $0.00 | 18,490 | D | $13.35 · — to 2027-03-16 | 10,500 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |